Somatostatin Receptor Positive (SSTR+)
Oncology·MeSH: Gastro-enteropancreatic neuroendocrine tumor
2 drugs in development·2 companies·1 clinical trial
Drug Pipeline by Phase
Phase 3(2)
Frequently asked questions
How many drugs are in development for Somatostatin Receptor Positive (SSTR+)?
BioSniper tracks 2 drugs in development for Somatostatin Receptor Positive (SSTR+) across 2 companies.
How many clinical trials target Somatostatin Receptor Positive (SSTR+)?
There are 1 clinical trial targeting Somatostatin Receptor Positive (SSTR+) tracked by BioSniper.
Deep-dive into Somatostatin Receptor Positive (SSTR+)
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis